BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15199340)

  • 1. Atrial fibrillation and atrial cardiomyopathy--two sides of the same coin?
    Pedersen OD; Køber L; Torp-Pedersen C
    Am Heart J; 2004 Jun; 147(6):953-5. PubMed ID: 15199340
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials.
    Boos CJ; Lip GY
    J Hum Hypertens; 2005 Nov; 19(11):855-9. PubMed ID: 16094406
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pathophysiology of the renin-angiotensin-system in atrial fibrillation].
    Heusch G; Schulz R
    Dtsch Med Wochenschr; 2006 Apr; 131(15):817-20. PubMed ID: 16607602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin system inhibitors for prevention of new-onset atrial fibrillation.
    Baker WL; White CM
    Conn Med; 2007 Apr; 71(4):205-9. PubMed ID: 17487005
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of suppressing the renin-angiotensin system on atrial fibrillation.
    Kalus JS; Coleman CI; White CM
    J Clin Pharmacol; 2006 Jan; 46(1):21-8. PubMed ID: 16397280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation and renin-angiotensin system.
    Serra JL; Bendersky M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials, the renin angiotensin system and atrial fibrillation.
    Birnie DH; Gollob M; Healey JS
    Curr Opin Cardiol; 2006 Jul; 21(4):368-75. PubMed ID: 16755207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.
    Healey JS; Morillo CA; Connolly SJ
    Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin system inhibitors and atrial fibrillation.
    Arbel Y; Glikson M
    Isr Med Assoc J; 2005 Jun; 7(6):388-91. PubMed ID: 15984384
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy.
    Ogimoto A; Shigematsu Y; Higaki J; Miki T
    Am Heart J; 2005 Mar; 149(3):566. PubMed ID: 15864221
    [No Abstract]   [Full Text] [Related]  

  • 12. [Atrial fibrillation: potential therapeutic interventions in the renin-angiotensin-aldosterone system].
    Dabrowski R; Szwed H
    Kardiol Pol; 2007 Apr; 65(4):440-5. PubMed ID: 17530565
    [No Abstract]   [Full Text] [Related]  

  • 13. Blockade of renin-angiotensin system: a supplementary treatment for circumferential pulmonary vein isolation in treating persistent atrial fibrillation.
    Dai SM; Zhang S; Chu JM; Guo YH; Chen KP; Yao Sy
    Med Hypotheses; 2007; 69(4):767-72. PubMed ID: 17475415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
    Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S
    Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin system component expression in the HL-1 atrial cell line and in a pig model of atrial fibrillation.
    Tsai CT; Lai LP; Hwang JJ; Chen WP; Chiang FT; Hsu KL; Tseng CD; Tseng YZ; Lin JL
    J Hypertens; 2008 Mar; 26(3):570-82. PubMed ID: 18300870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of rennin-angiotensin-aldosterone system blockade in the prevention of nonvalvular atrial fibrillation].
    Qi WH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):293-4. PubMed ID: 16776914
    [No Abstract]   [Full Text] [Related]  

  • 17. Preservation of sinus node function by Angiotensin converting enzyme inhibitors.
    Han X; Benditt DG
    J Cardiovasc Electrophysiol; 2005 Nov; 16(11):1215-7. PubMed ID: 16302907
    [No Abstract]   [Full Text] [Related]  

  • 18. The renin-angiotensin system: a therapeutic target in atrial fibrillation.
    Patlolla V; Alsheikh-Ali AA; Al-Ahmad AM
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):1006-12. PubMed ID: 16981926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathophysiology of atrial fibrillation: importance of the renin-angiotensin system].
    Schulz R; Heusch G
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35 Suppl 4):S95-8. PubMed ID: 16921449
    [No Abstract]   [Full Text] [Related]  

  • 20. Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation.
    Anand K; Mooss AN; Hee TT; Mohiuddin SM
    Am Heart J; 2006 Aug; 152(2):217-22. PubMed ID: 16875900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.